减毒百日咳疫苗BPZE1对小鼠肺炎球菌病提供短暂异源保护
本研究在小鼠侵袭性肺炎球菌病模型中评估减毒百日咳疫苗BPZE1的异源保护作用。单剂BPZE1无保护,间隔三周给予两剂10^6 CFU可降低BALB/c和C57BL/6小鼠的死亡率、肺部定植和播散,但保护短暂,加强后数日内消退。保护依赖活菌初免和MyD88介导的固有免疫。
要点
- 两剂BPZE1(间隔三周,10^6 CFU)对小鼠肺炎球菌感染提供短暂保护。
- 单剂BPZE1无保护作用,初免需活菌。
- 保护机制依赖固有免疫,MyD88敲除小鼠中保护消失。
核心结论
- BPZE1两剂接种对小鼠侵袭性肺炎球菌病提供短暂异源保护,单剂无效。
研究设计与样本
- 小鼠模型研究,使用BALB/c和C57BL/6小鼠及MyD88敲除小鼠。
主要发现
- 单剂BPZE1无保护作用。
- 间隔三周两剂10^6 CFU BPZE1可保护BALB/c和C57BL/6小鼠免受死亡、肺部定植和播散。
- 保护在加强接种后数日内减弱。
- 甲醛灭活BPZE1仅在活菌初免后给药才有保护作用。
- 保护与血液中细菌播散显著减少相关,且在MyD88敲除小鼠中消失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BPZE1 is a live attenuated vaccine against infection by Bordetella pertussis, the causative agent of whooping cough. It was previously shown that BPZE1 provides heterologous protection in mouse models of disease caused by unrelated pathogens, such as influenza virus and respiratory syncytial virus. Protection was also observed in mouse models of asthma and contact dermatitis. In this study, we demonstrate that BPZE1 also displays protection against an unrelated bacterial pathogen in a mouse model of invasive pneumococcal disease mediated by Streptococcus pneumoniae. While a single administration of BPZE1 provided no protection, two doses of 106 colony-forming units of BPZE1 given in a three-week interval protected against mortality, lung colonization and dissemination in both BALB/c and C57BL/6 mice. Unlike for the previously reported influenza challenge model, protection was short-lived, and waned within days after booster vaccination. Formaldehyde-killed BPZE1 protected only when administered following a live prime, indicating that priming requires live BPZE1 for protection. Protection against mortality was directly linked to substantially decreased bacterial dissemination in the blood and was lost in MyD88 knock-out mice, demonstrating the role of the innate immune system in the mechanism of protection. This is the first report on a heterologous protective effect of the live BPZE1 vaccine candidate against an unrelated bacterial infection.
引用
- Belcher T, Kammoun H, Coutte L, et al. Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice. Vaccine. 2021. PMID: 33509692. doi:10.1016/j.vaccine.2021.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。